HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Henry Walch Selected Research
Henry Walch Research Topics
Disease
13
Neoplasms (Cancer)
05/2024 - 01/2021
2
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 11/2021
1
Pancreatic Neoplasms (Pancreatic Cancer)
05/2024
1
Neoplasm Metastasis (Metastasis)
03/2024
1
Cholangiocarcinoma
02/2024
1
Stomach Neoplasms (Stomach Cancer)
10/2023
1
Aneuploidy (Aneuploid)
10/2023
1
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2023
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1
Brain Neoplasms (Brain Tumor)
01/2023
1
Adenocarcinoma
01/2022
1
Rectal Neoplasms (Rectal Cancer)
01/2022
1
Hemorrhage
11/2021
1
Abdominal Pain (Pain, Abdominal)
11/2021
1
Breast Neoplasms (Breast Cancer)
01/2021
1
Turcot syndrome
01/2021
Drug/Important Bio-Agent (IBA)
2
Genie
IBA
05/2024 - 07/2023
2
Immune Checkpoint Inhibitors
IBA
10/2023 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 11/2021
1
tyrosine receptor (receptor, tyrosine)
IBA
03/2024
1
Phosphotransferases (Kinase)
IBA
03/2024
1
Biological Factors
IBA
10/2023
1
Farnesyltranstransferase (Farnesyltransferase)
IBA
07/2023
1
tipifarnib (R115777)
IBA
07/2023
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2023
1
Heterochromatin
IBA
07/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
07/2023
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
07/2023
1
Tyrosine Kinase Inhibitors
IBA
01/2023
1
Circulating Tumor DNA
IBA
01/2023
1
Trastuzumab (Herceptin)
FDA Link
01/2023
1
alectinib
IBA
01/2023
1
pembrolizumab
IBA
01/2023
1
Small Cytoplasmic RNA
IBA
01/2023
1
zirconium-89-trastuzumab
IBA
01/2023
1
ErbB Receptors (EGF Receptor)
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Calcibiotic Root Canal Sealer
IBA
11/2021
1
Monoclonal Antibodies
IBA
11/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
01/2021
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
01/2021
Therapy/Procedure
4
Drug Therapy (Chemotherapy)
10/2023 - 01/2021
3
Therapeutics
03/2024 - 01/2023
2
Precision Medicine
05/2024 - 10/2023
1
Duration of Therapy
03/2024
1
Neoadjuvant Therapy
01/2022
1
Immunotherapy
01/2021